See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.

Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

Pharmacology Vesicular monoamine transporter 2 (VMAT2) is a protein that regulates the packaging and release of monoamines (dopamine, serotonin, norepinephrine, and histamine). VMAT2 inhibitors …

Austedo is a prescription medication that is used to treat the involuntary movements (chorea) of Huntington's disease. The most common side effects of Austedo in people with tardive dyskinesia …

Jun 27, 2024 · Learn about uses, side effects, and more for Austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to Huntington’s disease.

Sep 25, 2025 · Learn more about Austedo dosage, including available strengths, forms, and how it’s taken.

Sep 21, 2025 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine)...

May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.

Jun 3, 2024 · The FDA has approved Austedo XR in four new tablet strengths for adults diagnosed with tardive dyskinesia and chorea associated with Huntington’s disease, according to the …